oxidant < oxidase < oxidation

Facettes :

List of bibliographic references indexed by oxidase

Number of relevant bibliographic references: 21.
[0-20] [0 - 20][0 - 21][20-20][20-40]

Ident.	Authors (with country if any)	Title
000780 (2010)	Tamar Goren [Israël] ; Liat Adar [Israël] ; Nissim Sasson [Israël] ; Yoni M. Weiss [Israël]	Clinical Pharmacology Tyramine Challenge Study to Determine the Selectivity of the Monoamine Oxidase Type B (MAO‐B) Inhibitor Rasagiline
001008 (2007)	Fernandez [États-Unis] ; Chen [États-Unis]	Monoamine Oxidase‐B Inhibition in the Treatment of Parkinson's Disease
001178 (2006)	Moussa B. H. Youdim [Israël] ; Dale Edmondson [États-Unis] ; Keith F. Tipton [Irlande (pays)]	The therapeutic potential of monoamine oxidase inhibitors
001565 (2004)	M. Białecka ; M. Dro Dzik ; G. Kłodowska-Duda ; K. Honczarenko ; B. Gawro Ska-Szklarz ; G. Opala ; J. Stankiewicz [Pologne]	The effect of monoamine oxidase B (MAOB) and catechol‐O‐methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease
001600 (2004)	Rinat Tabakman [Israël] ; Shimon Lecht [Israël] ; Philip Lazarovici [Israël]	Neuroprotection by monoamine oxidase B inhibitors: a therapeutic strategy for Parkinson's disease?
001606 (2004)	Natalie J. Ives ; Rebecca L. Stowe ; Joanna Marro ; Carl Counsell ; Angus Macleod ; Carl E. Clarke ; Richard Gray ; Keith Wheatley	Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patients
001660 (2004)	Paola Costa-Mallen [États-Unis] ; Zahra Afsharinejad [États-Unis] ; Samir N. Kelada [États-Unis] ; Lucio G. Costa [États-Unis, Italie] ; Gary M. Franklin [États-Unis] ; Phillip D. Swanson [États-Unis] ; W. T. Longstreth Jr. [États-Unis] ; Hannah-Malia A. Viernes [États-Unis] ; Federico M. Farin [États-Unis] ; Terri Smith-Weller [États-Unis] ; Harvey Checkoway [États-Unis]	DNA sequence analysis of monoamine oxidase B gene coding and promoter regions in Parkinson's disease cases and unrelated controls
001C66 (2000)	Iris Maurer [Allemagne] ; Stephan Zierz [Allemagne] ; Hans Rgen Möller [Allemagne]	A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients
002057 (1997)	Paola Costa [États-Unis] ; Harvey Checkoway [États-Unis] ; Drew Levy [États-Unis] ; Terri Smith-Weller [États-Unis] ; Gary M. Franklin [États-Unis] ; Phillip D. Swanson [États-Unis] ; Lucio G. Costa [États-Unis]	Association of a polymorphism in intron 13 of the monoamine oxidase B gene with Parkinson disease
002159 (1996)	T. Salonen ; Antti Haapalinna ; Esa Heinonen ; Jaana Suhonen [États-Unis] ; Antti Hervonen	Monoamine oxidase B inhibitor selegiline protects young and aged rat peripheral sympathetic neurons against 6-hydroxydopamine-induced neurotoxicity
002196 (1996)	M. Battino ; P. Littarru ; A. Gorini [Italie] ; F. Villa [Italie]	Coenzyme Q, peroxidation and cytochrome oxidase features after Parkinson's-like disease by MPTP toxicity in intra-synaptic and non-synaptic mitochondria from Macaca Fascicularis cerebral cortex and hippocampus: action of dihydroergocriptine
002425 (1994)	S. Umeki [Japon]	Mechanisms for the activation/electron transfer of neutrophil NADPH-oxidase complex and molecular pathology of chronic granulomatous disease
002436 (1994)	Gokhan S. Hotamisligil [États-Unis] ; A. Sule Girmen [États-Unis] ; J. Stephen Fink [États-Unis] ; Elizabeth Tivol [États-Unis] ; Christo Shalish [États-Unis] ; James Trofatter [États-Unis] ; John Baenziger [États-Unis] ; Shirley Diamond [États-Unis] ; Charles Markham [États-Unis] ; Jack Sullivan [États-Unis] ; John Growdon [États-Unis] ; Xandra O. Breakefield [États-Unis]	Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease
002549 (1993)	H. Heinonen [Finlande] ; M. Savij Rvi [Finlande] ; M. Kotila [Finlande] ; A. Hajba [Finlande] ; M. Scheinin [Finlande]	Effects of monoamine oxidase inhibition by selegiline on concentrations of noradrenaline and monoamine metabolites in CSF of patients with Alzheimer's disease
002552 (1993)	H. Youdim [Israël] ; P. Riederer [Allemagne]	Dopamine metabolism and neurotransmission in primate brain in relationship to monoamine oxidase A and B inhibition
002825 (1989)	H. Lee [États-Unis] ; M. Mendoza [États-Unis] ; T. Dvorozniak [États-Unis] ; E. Chung [États-Unis] ; H. Van Woert [États-Unis] ; D. Yahr [États-Unis]	Platelet monoamine oxidase in Parkinson patients: effect of L-deprenyl therapy
002869 (1988)	H. Youdim [Israël]	Platelet monoamine oxidase B: Use and misuse
002876 (1988)	F. Parkinson [États-Unis] ; G. Gabig [États-Unis]	Isolation of the respiratory burst oxidase: The role of a flavoprotein component
002A84 (1983)	P. Riederer [Autriche] ; K. Jellinger [Autriche]	Neurochemical insights into monoamine oxidase inhibitors, with special reference to deprenyl (selegiline)
002B41 (1981)	C. J. Fowler [Irlande (pays)] ; L. Oreland [Suède] ; B. A. Callingham [Royaume-Uni]	The acetylenic monoamine oxidase inhibitors clorgyline, deprenyl, pargyline and J‐508: their properties and applications
002B68 (1980)	David Parkinson [Royaume-Uni] ; Geoffrey A. Lyles [Royaume-Uni] ; Barbara J. Browne [Royaume-Uni] ; Brian A. Callingham [Royaume-Uni]	Some factors influencing the metabolism of benzylamine by type A and B monoamine oxidase in rat heart and liver

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "oxidase" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "oxidase" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    oxidase
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024